Registration - Consultant

Alliance of Safe Biologic Medicines / Giancarlo Drennan, Consultant

Registration Information

Client name: Alliance of Safe Biologic Medicines
Lobbyist name: Giancarlo Drennan, Consultant
Initial registration start date: 2017-07-14
Registration status: Inactive
Registration Number: 810770-360292

Associated Communications

Total Number of Communication Reports: 14

Monthly communication reports in the last 6 months: 0

Version 2 of 2 (2018-03-29 to 2020-11-13)

Lobbying Information

Subject Matters

Budget
Consumer Issues
Economic Development
Health
Intellectual Property
Research and Development
Science and Technology

Subject Matter Details

Policies or Program

Assisting ASBM advocate for the affordability and accessibility of biologic medications. To ensure patient safety, the aim is policy that keeps medical decisions between patients and physicians.

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Finance Canada (FIN)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
PO Box 3691
Arlington, VA 22203
United States of America

Telephone number: 703-971-1700

Client representative

Ray Patnaude, Program Manager

Parent Company Information

Alliance of Safe Biologic Medicines is not a subsidiary of any other parent companies.

Coalition Members Information

Alliance of Safe Biologic Medicines is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Alliance of Safe Biologic Medicines are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Alliance of Safe Biologic Medicines does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Giancarlo Drennan | No public offices held

Business address:
151 Bloor Street West
Suite 810
Toronto, ON M5S 1S4
Canada

Telephone number: 416-294-3738

Consultant Firm and Address

Firm: Maple Leaf Strategies

Address:
151 Bloor Street West
Suite 810
Toronto, ON M5S 1S4
Canada

Telephone number: 416-620-7111

Alliance of Safe Biologic Medicines/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Alliance of Safe Biologic Medicines/	2017-07-14	2020-11-13

Alliance of Safe Biologic Medicines

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Giancarlo Drennan, Maple Leaf Strategies (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-14 of 14

Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Anthony Ridgway, Senior Regulatory Scientist | Director's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-12-13
Posted date: 2018-12-13
Communication number: 360292-441819 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Stephanie Hardy, Manager, Policy Unit | Office of Policy and International Collaboration | Health Canada (HC)
- Anthony Ridgway, Senior Regulatory Scientist | Director's Office | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-12-07
Posted date: 2018-12-13
Communication number: 360292-441816 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Stephanie Hardy, Manager, Policy Unit | Office of Policy and International Collaboration | Health Canada (HC)
- Anthony Ridgway, Senior Regulatory Scientist, | Director's Office | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-11-27
Posted date: 2018-12-13
Communication number: 360292-441815 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Stephanie Hardy, Manager, Policy Unit | OFFICE OF POLICY AND INTERNATIONAL COLLABORATION | Health Canada (HC)
- Anthony Ridgway, Senior Regulatory Scientist, Director's Office | DIRECTOR'S OFFICE | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2018-09-27
Posted date: 2018-10-15
Communication number: 360292-436070 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Stephanie Hardy, Manager | Office of Policy and International Collaboration | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-06-28
Posted date: 2018-07-06
Communication number: 360292-430147 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Cathy Parker, Director General | Biologics and Genetic Therapies Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-06-18
Posted date: 2018-07-06
Communication number: 360292-430145 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Anthony Ridgway, Senior Regulatory Scientist | Biologics and Genetic Therapies Directorate | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-04-04
Posted date: 2018-04-24
Communication number: 360292-424682 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Cathy Parker, Director General | Biologics and Genetic Therapies Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-03-28
Posted date: 2018-03-29
Communication number: 360292-422884 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Cathy Parker, Director General | Biologics and Genetic Therapies Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-03-06
Posted date: 2018-03-29
Communication number: 360292-422926 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Anthony Ridgway, Assistant Director | Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
- Georgette Roy, Director | Office of Regulatory Affairs | Health Canada (HC)
- Stephanie Hardy, Manager | Office of Policy and International Collaboration | Health Canada (HC)
- Parag Buch, Subject Matter Technical Specialist | Office of Policy and International Collaboration | Health Canada (HC)
- Vincent Panetta, Regulatory Affairs Supervisor | Office of Regulatory Affairs | Health Canada (HC)
- Sandra Alderdice, Regulatory Affairs Supervisor | Office of Regulatory Affairs | Health Canada (HC)
- Jian Wang, Chief, Clinical Evaluation Division | Heamatology & Oncology, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
- Kenneth Joly, Policy Analyst | Office of Policy and International Collboration | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2017-10-04
Posted date: 2017-10-18
Communication number: 360292-410428 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Bill Casey, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-10-04
Posted date: 2017-10-06
Communication number: 360292-408864 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Tyler Meredith, Policy Advisor | Office of the Prime Minister | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2017-10-04
Posted date: 2017-10-06
Communication number: 360292-408863 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Javid Dharas, Policy Advisor | Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Science and Technology
Communication date: 2017-10-04
Posted date: 2017-10-06
Communication number: 360292-408861 View associated registration
Alliance of Safe Biologic Medicines
Consultant: Giancarlo Drennan

Designated Public Office Holders who participated in the communication:
- Christina Lararova, Special Assistant - Quebec & Atlantic | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2017-10-04
Posted date: 2017-10-06
Communication number: 360292-408860 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Alliance of Safe Biologic Medicines / Giancarlo Drennan, Consultant

Registration Information

Associated Communications

Version 2 of 2 (2018-03-29 to 2020-11-13)

Version 2 of 2 (2018-03-29 to 2020-11-13)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address